These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15311133)

  • 1. F-18 FDG positron emission tomography imaging of rare soft tissue sarcomas: low-grade fibromyxoid sarcoma and malignant hemangiopericytoma.
    Williams HT; Gossage JR; Allred TJ; Kallab AM; Pancholy A; Anstadt MP
    Clin Nucl Med; 2004 Sep; 29(9):581-4. PubMed ID: 15311133
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.
    Schwarzbach MH; Dimitrakopoulou-Strauss A; Willeke F; Hinz U; Strauss LG; Zhang YM; Mechtersheimer G; Attigah N; Lehnert T; Herfarth C
    Ann Surg; 2000 Mar; 231(3):380-6. PubMed ID: 10714631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of fluorine-18 fluorodesoxyglycose-positron emission tomography for treatment monitoring in patients with soft tissue sarcomas.
    Kasper B; Hohenberger P; Strauss LG; Dimitrakopoulou-Strauss A
    Hell J Nucl Med; 2010; 13(1):40-4. PubMed ID: 20411170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [18F-FDG-PET-CT in soft tissue sarcomas: when to image?].
    Rodríguez-Alfonso B; Mucientes Rasilla J; Mitjavila Casanovas M; Cardona Arboniés J; Cubedo R
    Rev Esp Med Nucl Imagen Mol; 2014; 33(1):43-9. PubMed ID: 24094372
    [No Abstract]   [Full Text] [Related]  

  • 5. Sarcoma.
    Ceyssens S; Stroobants S
    Methods Mol Biol; 2011; 727():191-203. PubMed ID: 21331935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
    Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM
    PET Clin; 2015 Jul; 10(3):375-93. PubMed ID: 26099673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative dynamic ¹⁸FDG-PET and tracer kinetic analysis of soft tissue sarcomas.
    Rusten E; Rødal J; Revheim ME; Skretting A; Bruland OS; Malinen E
    Acta Oncol; 2013 Aug; 52(6):1160-7. PubMed ID: 23198721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glut-1 expression and enhanced glucose metabolism are associated with tumour grade in bone and soft tissue sarcomas: a prospective evaluation by [18F]fluorodeoxyglucose positron emission tomography.
    Tateishi U; Yamaguchi U; Seki K; Terauchi T; Arai Y; Hasegawa T
    Eur J Nucl Med Mol Imaging; 2006 Jun; 33(6):683-91. PubMed ID: 16506050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contemporary imaging in sarcoma.
    Landa J; Schwartz LH
    Oncologist; 2009 Oct; 14(10):1021-38. PubMed ID: 19789392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Positron emission tomography with fluorine-deoxyglucose in sarcomas and non-sarcoma non-epithelial tumors].
    Massardo T; Jofré MJ; Sierralta MP; Canessa J; Castro G; Berrocal I; Gallegos I
    Rev Med Chil; 2012 Sep; 140(9):1116-25. PubMed ID: 23354632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-fluorodeoxyglucose uptake of bone and soft tissue sarcomas in pediatric patients.
    Walter F; Federman N; Apichairuk W; Nelson S; Phelps ME; Allen-Auerbach M; Walter MA; Czernin J
    Pediatr Hematol Oncol; 2011 Oct; 28(7):579-87. PubMed ID: 21936620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of uterine sarcomas.
    Nagamatsu A; Umesaki N; Li L; Tanaka T
    Oncol Rep; 2010 Apr; 23(4):1069-76. PubMed ID: 20204293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of Choline-PET for the detection of residual hemangiopericytoma in the skull base: comparison with FDG-PET.
    Ito S; Yokoyama J; Yoshimoto H; Yazawa M; Kazuo K; Hanaguri M; Ohba S; Fujimaki M; Ikeda K
    Head Face Med; 2012 Feb; 8():3. PubMed ID: 22314195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography imaging in uterine sarcomas: systematic review and meta-analysis of the literature.
    Sadeghi R; Zakavi SR; Hasanzadeh M; Treglia G; Giovanella L; Kadkhodayan S
    Int J Gynecol Cancer; 2013 Oct; 23(8):1349-56. PubMed ID: 23945203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of positron emission tomography in the management of patients with sarcoma.
    Benz MR; Tchekmedyian N; Eilber FC; Federman N; Czernin J; Tap WD
    Curr Opin Oncol; 2009 Jul; 21(4):345-51. PubMed ID: 19412096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 18F-FDG PET-CT in soft tissue sarcomas: staging, restaging, and prognostic value?
    Gabriel M; Rubello D
    Nucl Med Commun; 2016 Jan; 37(1):3-8. PubMed ID: 26457597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-fluorodeoxyglucose positron emission tomography as a noninvasive method for the diagnosis of primary pulmonary artery sarcoma.
    Dias OM; Lombardi EM; Canzian M; Soares Júnior J; Vieira Lde O; Terra Filho M
    J Bras Pneumol; 2011; 37(6):817-22. PubMed ID: 22241041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of
    Kassem TW; Abdelaziz O; Emad-Eldin S
    Diagn Interv Imaging; 2017 Oct; 98(10):693-698. PubMed ID: 28734778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple FDG-avid sclerosing hemangiomas mimicking pulmonary metastases in a case of soft tissue sarcoma.
    Purandare NC; Dua SG; Shah S; Sharma AR; Suryawanshi PV; Rangarajan V
    Cancer Imaging; 2010 Jul; 10(1):169-72. PubMed ID: 20675249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of positron emission tomography in sarcomas.
    Schuetze SM
    Curr Opin Oncol; 2006 Jul; 18(4):369-73. PubMed ID: 16721133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.